Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Vivos Therapeutics Inc (NQ: VVOS )

3.200 +0.250 (+8.47%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vivos Therapeutics Inc

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why ImmuCell Are Trading Higher; Here Are 20 Stocks Moving Premarket
Gainers Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares surged 131.6% to $4.03 in pre-market trading after gaining 15% on Tuesday. 
Via Benzinga
Looking Into Vivos Therapeutics's Return On Capital Employed
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q1 2023 Financial Numbers, Corporate Update
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
Vivos Therapeutics: Q1 Earnings Insights
Via Benzinga
A Preview Of Vivos Therapeutics's Earnings
Via Benzinga
Earnings Scheduled For June 8, 2023
Companies Reporting Before The Bell • Signet Jewelers (NYSE:SIG) is expected to report quarterly earnings at $1.24 per share on revenue of $1.65 billion. 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Plans to Release Q1 2023 Financial Numbers, Host Earnings Call
Via Investor Brand Network
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
It's time for a dive into the biggest pre-market stock movers for Friday as we check out the winners and losers this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Featured in Proactive Studio Podcast
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces New Strategic Initiatives
Via Investor Brand Network
Exposures COVID-19
A Headache-Free Future? Vivos' POD Device Slashes Migraine Symptoms by 89% in Clinical Study
Vivos Therapeutics Inc (NASDAQ: VVOS) announced the results of a recent clinical observational study on the application of Vivos' Preventive Oral Device, dubbed POD, for treating and  
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Reports on ‘Game-Changing’ Appliance Treatment for Migraines
Via Investor Brand Network
Exposures Product Safety
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Releases Q4, FY Financial and Operational Report
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Schedules Release of Q4 and FY 2022 Results, Conference Call
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) to Participate at 35th Annual ROTH Conference
Via Investor Brand Network
Why Aclaris Therapeutics Shares Are Trading Lower By Around 55%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Unicycive Therapeutics, Inc. (NASDAQ: UNCY) shares surged 159% to $1.27 after the company announced a private placement of up to $130 million in gross proceeds to commercialize and launch... 
Via Benzinga
Why Hertz Global Shares Are Trading Higher By Around 5%; Here Are 20 Stocks Moving Premarket
Gainers Secoo Holding Limited (NASDAQ: SECO) rose 44% to $1.44 in pre-market trading after dipping over 31% on Friday. 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Expands Product Portfolio, Revenue Potential Through Strategic Acquisition
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Participation at Emerging Growth Conference
Via Investor Brand Network
7 Micro-Cap Stocks to Buy for Risk-Taking Investors
These micro-cap stocks to buy have tremendous growth potential and a history of big moves, but they also come with plenty of volatility. 
Via InvestorPlace
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Regains Compliance with Nasdaq Listing Requirements
Via Investor Brand Network
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Announces Closing of $8M Private Placement
Via Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For January 17, 2023
Via Benzinga
Why Spruce Biosciences Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 133% to $0.3218. Swvl recently announced the commencement of a strategic review process. 
Via Benzinga
InvestorNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Enters into Private Placement Agreement
Via Investor Brand Network
Why ABVC BioPharma Shares Are Trading Higher By 129%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Bellerophon Therapeutics, Inc. (NASDAQ: BLPH) shares surged 179.3% to $2.4585 after the company announced that it has entered into a license agreement for the development and commercialization... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.